Parathyroid hormone (PTH) is the body’s primary regulator of blood calcium, secreted by four small glands embedded behind the thyroid in the neck. When blood calcium dips even slightly, PTH floods the bloodstream and pulls calcium from bone, signals the kidneys to hold onto calcium while dumping phosphate, and jumpstarts vitamin D activation so the gut absorbs more calcium from food. That three-pronged response keeps blood calcium locked within a remarkably tight range, which is essential because calcium controls everything from nerve signaling to heartbeat rhythm. But the story of PTH extends well beyond calcium balance, touching bone density, kidney health, mental well-being, and an evolutionary history that stretches back to when our ancestors first crawled out of the water.
How the Parathyroid Glands Know When to Act
The parathyroid glands are studded with calcium-sensing receptors (CaSRs), proteins on the cell surface that act like molecular thermostats for blood calcium. When circulating calcium rises, CaSRs detect the change and shut down PTH release. When calcium falls, CaSR signaling eases off and PTH pours out. This feedback loop operates on a minute-to-minute basis, allowing the body to correct small fluctuations before they become dangerous.1PubMed. Role of the calcium-sensing receptor in parathyroid gland physiology Beyond just toggling PTH secretion, CaSR signaling also influences how much PTH the glands produce at the gene level and even how fast the gland cells multiply.
PTH secretion is not constant throughout the day. It follows a genuine circadian rhythm, dipping to its lowest point in the morning around 9:30 a.m. and climbing through the afternoon into the evening.2PubMed. Circadian rhythm and pulsatility of parathyroid hormone secretion in man This is not just a side effect of eating patterns or activity. Researchers confirmed the rhythm persists under carefully controlled conditions that remove all external time cues, proving it is a true internal clock.3PubMed. The parathyroid hormone circadian rhythm is truly endogenous–a general clinical research center study The practical implication is that a single PTH blood draw in the morning will usually show a lower value than the same test done in the afternoon, something clinicians have to keep in mind when interpreting results.
What PTH Does in the Kidneys
The kidneys are PTH’s busiest workplace. Every day, your kidneys filter a large amount of calcium out of the blood, and most of it gets recaptured before reaching the urine. PTH fine-tunes this process in the distal part of the kidney tubule, where it ramps up a sodium-calcium exchange system that pulls calcium back into the bloodstream.4PubMed. The mechanism of parathyroid hormone action on calcium reabsorption by the distal tubule The exchanger sits exclusively in the distal tubule, which is why PTH’s calcium-saving effect is so precisely targeted.5PubMed. Effects of parathyroid hormone on renal tubular calcium and phosphate handling
While PTH saves calcium, it does the opposite with phosphate. In the proximal tubule, PTH triggers the removal of sodium-phosphate cotransporters from the cell surface, which means less phosphate gets reabsorbed and more spills into the urine.6PubMed. Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters Animal studies have confirmed that surgically removing the parathyroid glands causes these phosphate transporters to pile up in the kidney cell membranes, and that a dose of PTH reverses the effect within hours.7PubMed. Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter Dumping phosphate serves a purpose: high phosphate in the blood binds to calcium and drops the level of free calcium, which is exactly what PTH is trying to raise. So the phosphate dump and the calcium save work hand in hand.
The PTH–Vitamin D Partnership
Vitamin D from sunlight or food is biologically inert until the body converts it into its active form. The final activation step happens in the kidneys, and PTH is the main signal that flips the switch. PTH stimulates the enzyme (called 1-alpha-hydroxylase) that produces active vitamin D, which then travels to the intestine and ramps up calcium absorption from food.8PubMed Central. PTH and Vitamin D Recent research has pinpointed the molecular relay in this process: PTH deactivates a family of enzymes called salt-inducible kinases in the proximal tubule, which in turn allows genes for vitamin D activation to turn on. Mice engineered to lack these kinases produce excess active vitamin D and develop high calcium levels even without any PTH signal, confirming that these kinases are the gatekeepers.9JCI Insight. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The partnership runs both directions. Once vitamin D is activated, it circles back and suppresses PTH secretion by the parathyroid glands.10PubMed Central. PTH and Vitamin D This negative feedback loop means that vitamin D deficiency removes the brake on PTH. That is why people with chronically low vitamin D often develop elevated PTH levels, a condition called secondary hyperparathyroidism, which over time can thin bones.
The Bone Paradox
PTH has a reputation as a bone-destroying hormone, but the reality is more nuanced and, frankly, a bit paradoxical. Whether PTH builds bone or breaks it down depends almost entirely on how the body is exposed to it.
When PTH is constantly elevated, as happens in chronic hyperparathyroidism, it tips the balance toward bone resorption. It does this by boosting the production of a molecule called RANKL in bone-forming cells, which recruits and activates bone-eating cells (osteoclasts). The result, over months and years, can be thinning bones, focal resorption, and a condition historically called osteitis fibrosa.11PubMed Central. Parathyroid hormone: anabolic and catabolic actions on the skeleton
Give the same hormone in brief daily pulses, though, and the opposite happens. Intermittent PTH exposure activates a different set of downstream signals, particularly suppressing a protein called sclerostin in bone cells, which unleashes a bone-building pathway. In animal experiments, intermittent PTH increased both the thickness and the number of bone trabeculae, while the same total dose delivered as a continuous infusion failed to increase bone mass at all.12PubMed. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone Both exposure patterns stimulate bone formation, but only the intermittent pattern consistently adds more bone than it removes.
When PTH Runs Too High
In primary hyperparathyroidism, one or more parathyroid glands grow out of control and secrete too much PTH regardless of how high blood calcium climbs. It is one of the more common endocrine disorders, and its signs can be sneaky. Bone thinning and kidney stones are the classic complications, but patients also report joint pain, muscle weakness, fatigue, and mood changes that overlap with rheumatic diseases like fibromyalgia and rheumatoid arthritis, sometimes delaying diagnosis.13PubMed Central. Primary hyperparathyroidism: clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines Surgery to remove the overactive gland remains the definitive treatment.
Secondary hyperparathyroidism is a different beast. Here the parathyroids are responding appropriately to a real problem, usually chronic kidney disease (CKD). Failing kidneys cannot excrete phosphate efficiently or activate vitamin D properly, so blood calcium drops and PTH rises in compensation. Another hormone, FGF23, rises early in CKD to help push phosphate into the urine and normally acts directly on the parathyroid glands to restrain PTH. But as kidney disease advances, the parathyroid glands become resistant to FGF23, partly because they lose the receptor complex (Klotho-FGFR1) needed to hear FGF23’s signal.14PubMed. FGF23-parathyroid interaction: implications in chronic kidney disease The parathyroids then enlarge and churn out PTH unchecked. Interestingly, attempts to simply neutralize FGF23 in animal models of CKD did improve PTH and bone markers, but the resulting spike in blood phosphate led to blood-vessel calcification and increased mortality, showing how intertwined these mineral pathways really are.15JCI Insight. FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
When PTH Runs Too Low
Hypoparathyroidism, a shortage of PTH, is most often an accidental consequence of thyroid or neck surgery that damages the parathyroid glands. Without enough PTH, blood calcium drops and phosphate rises. Symptoms range from tingling around the lips and fingers to muscle cramps, seizures, and abnormal heart rhythms. The standard treatment has long been calcium supplements and active vitamin D analogs to replace what PTH would normally orchestrate. Thiazide diuretics are sometimes added to reduce calcium losses in the urine. PTH analog replacement has emerged as a newer option, though cost remains a significant barrier.16PubMed Central. Treatment options in hypoparathyroidism
The Magnesium Wrinkle
Magnesium has a peculiar relationship with PTH that catches clinicians off guard. Mild drops in magnesium do what you would expect: they stimulate PTH release. But when magnesium falls very low, PTH secretion paradoxically shuts down, leading to hypocalcemia that refuses to correct until magnesium is restored.17PubMed. Magnesium and the parathyroid The mechanism appears to involve inappropriate activation of the calcium-sensing receptor’s downstream signaling, essentially fooling the parathyroid gland into thinking calcium is normal when it is not.
Severe magnesium deficiency also blunts the body’s response to PTH even after PTH levels start to recover. Classic studies showed that in magnesium-depleted patients, giving them PTH did not raise calcium as expected. Their bones appeared resistant to PTH’s signal, likely because the intracellular messenger system that PTH relies on needs magnesium to function properly.18PubMed. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency Bone-perfusion experiments confirmed this directly: magnesium-deficient bone took up less PTH and produced less of the expected signaling response.19The Journal of Clinical Investigation. Evidence for Skeletal Resistance to Parathyroid Hormone in Magnesium Deficiency: STUDIES IN ISOLATED PERFUSED BONE The clinical takeaway is straightforward: if a patient has low calcium that is not responding to treatment, check magnesium.
Pseudohypoparathyroidism
Some people produce plenty of PTH but their bodies cannot hear it. This group of rare inherited conditions, collectively called pseudohypoparathyroidism (PHP), results from defects in the signaling pathway that PTH uses inside cells. In the most studied form, PHP type 1a, the problem traces to mutations in the GNAS gene, which encodes a protein (Gsα) that relays PTH’s signal from the cell surface to the interior.20PubMed Central. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders The mutations cut Gsα protein activity roughly in half.
Here is where genetics gets interesting. The GNAS gene is imprinted, meaning its behavior depends on which parent passed it on. If the mutation comes from the mother, the child develops full-blown PHP1a with low calcium, high phosphate, and a set of physical features called Albright’s hereditary osteodystrophy (short stature, round face, shortened hand bones). If the same mutation comes from the father, the child gets the physical features but not the calcium problems.21The Journal of Clinical Endocrinology & Metabolism. Molecular Definition of Pseudohypoparathyroidism Variants The resistance is not limited to PTH either; other hormones that use the same Gsα relay, including thyroid-stimulating hormone and certain reproductive hormones, can also be affected.22PubMed Central. Pseudohypoparathyroidism
PTH-Based Therapies for Osteoporosis
The bone paradox described earlier opened the door to one of the more creative applications in medicine: using a bone-destroying hormone to treat bone loss. Teriparatide, a synthetic version of the first 34 amino acids of PTH, was the first anabolic osteoporosis drug. Injected once daily, it mimics the brief, intermittent PTH pulse that favors bone building over bone removal.23PubMed Central. Anabolic therapy for osteoporosis: update on efficacy and safety
A newer drug, abaloparatide, was engineered from a related molecule called parathyroid hormone-related protein (PTHrP). Both PTH and PTHrP activate the same receptor, but they do so differently. Teriparatide binds the receptor tightly and triggers a prolonged signaling response that, over time, also increases bone resorption and can raise blood calcium. Abaloparatide binds more briefly, producing the bone-building signal without as much of the resorptive or calcium-raising side effect. In clinical trials of women with osteoporosis, abaloparatide increased bone density faster than teriparatide and reduced both vertebral and non-vertebral fracture risk, with less hypercalcemia.24PubMed. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide Both drugs are given by daily injection and are typically limited to about two years of use, after which patients transition to an antiresorptive medication to lock in the gains.
Calcimimetics and Lowering PTH Without Surgery
For patients whose PTH is too high but who are not candidates for surgery, calcimimetic drugs offer a pharmacologic alternative. Cinacalcet, the most widely used, works by making the calcium-sensing receptor on parathyroid cells more sensitive to whatever calcium is already in the blood. This tricks the glands into thinking calcium is higher than it is, so they dial back PTH release.25PubMed. The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies
In hemodialysis patients with secondary hyperparathyroidism, long-term cinacalcet treatment lowers PTH, calcium, and phosphate levels.26Nephrology Dialysis Transplantation. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl In primary hyperparathyroidism, a study following 61 patients found that cinacalcet normalized blood calcium in about three-quarters of cases, though it brought PTH fully into range in only about 30%.27Endocrine Journal. Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience Calcimimetics are therefore effective at managing high calcium, which is usually the more dangerous problem, even when they do not fully normalize PTH itself.
PTH and Mental Health
Patients with hyperparathyroidism frequently report brain fog, difficulty concentrating, depression, and anxiety, complaints that often go uninvestigated because they seem unrelated to a calcium disorder. But the evidence for a genuine connection is growing. In a population-based study of older adults, those with elevated PTH scored worse on tests of attention, processing speed, and short-term memory, and had higher depression scores on standardized questionnaires, compared to people with normal PTH levels.28PubMed. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study A separate large study of older adults found that PTH levels were about a third higher in people with major depression than in non-depressed individuals, an association that held even after accounting for age, weight, and other chronic illnesses.29JAMA Psychiatry. Depression Is Associated With Decreased 25-Hydroxyvitamin D and Increased Parathyroid Hormone Levels in Older Adults
Perhaps the most compelling evidence comes from surgical studies. When patients with primary hyperparathyroidism had their overactive gland removed, their depression and anxiety symptoms improved at every follow-up visit. The drop in PTH after surgery was specifically associated with a decrease in anxiety and an improvement in visual and verbal memory.30PubMed. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism The mechanisms are still being worked out. Calcium itself is critical for neurotransmitter release and nerve function, so chronic hypercalcemia could directly disrupt brain chemistry. But the correlation between PTH specifically (not just calcium) and cognitive test scores suggests the hormone may also act on the brain through pathways that are not yet fully mapped.
Measuring PTH in the Lab
If your doctor orders a PTH blood test, the result you get depends on which generation of assay the lab uses, a detail that rarely makes it onto the report. Second-generation “intact PTH” assays, which are the most common, detect the full 84-amino-acid PTH molecule but also pick up a large fragment (amino acids 7–84) that is biologically less active. Third-generation “bio-intact” or “whole PTH” assays were designed to measure only the full-length molecule and exclude that fragment.31PubMed Central. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients As a result, second-generation assays tend to read higher than third-generation assays for the same blood sample.32PubMed. A method comparison of the Roche intact PTH method versus the Roche whole PTH (1-84) method: Examining the differences based on eGFR
For most patients, either assay works fine clinically. The discrepancy becomes more meaningful in kidney disease, where those 7–84 fragments accumulate because the kidneys cannot clear them efficiently. Clinical guidelines account for this difference, but it is worth knowing that reference ranges are not interchangeable between assay types.33Endocrine Reviews. Clinical Guidelines and PTH Measurement: Does Assay Generation Matter?
PTH-Related Protein and Cancer
PTH has a molecular cousin called parathyroid hormone-related protein (PTHrP), which binds the same receptor on cells but normally serves very different roles, including guiding fetal development and regulating smooth muscle tone. The problem arises when certain cancers, particularly squamous cell carcinomas and some breast and kidney tumors, begin producing PTHrP in large quantities. The resulting syndrome, humoral hypercalcemia of malignancy, is one of the most common life-threatening complications of advanced cancer.34PubMed. Humoral hypercalcemia of malignancy: some enigmas on the clinical features Because PTHrP mimics PTH at the receptor level, it drives calcium out of bone and into the blood just as PTH would, but the parathyroid glands themselves are actually suppressed by the resulting high calcium. That distinction matters diagnostically: in cancer-related hypercalcemia, PTH is low while PTHrP is high, the mirror image of what you see in primary hyperparathyroidism.
How the Parathyroid Gland Evolved From Gills
Fish do not have parathyroid glands. They live surrounded by calcium-rich water, absorbing it through their gills, and have no need for an internal calcium-recovery organ. When vertebrates made the transition to land roughly 370 million years ago, that easy access to dissolved calcium vanished. Research on gill tissue in zebrafish and other species has shown that the cells responsible for calcium transport in fish gills share gene-expression patterns and developmental origins with the cells of the tetrapod parathyroid gland, supporting the conclusion that the parathyroid gland evolved directly from gill tissue during the water-to-land transition.35PubMed Central. The origin of the parathyroid gland
The evolutionary story has another twist. Zebrafish have a form of parathyroid hormone, called Pth4, that is expressed not in a gland but in neurons of the hypothalamus, a brain region. Pth4 appears to regulate bone development and mineral balance through a brain-to-bone signaling route. This ancient gene was lost somewhere along the lineage that led to placental mammals, including humans, which suggests that our ancestors shifted mineral control away from the brain and toward the dedicated endocrine glands we have today.36PubMed Central. Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway In a sense, every time your parathyroid glands pulse out PTH to keep your blood calcium steady, they are doing the job that fish gills once handled in an entirely different medium.